Back to 
Woodline Partners LP
Woodline Partners LP
ABCL
Showing 1 of 9 quarters
Position history for Woodline Partners LP's holdings in AbCellera Biologics Inc.
No. Woodline Partners exited its ABCL (AbCellera Biologics) position in Q3 2024. Its Q2 2024 13F listed 12,163 shares worth $36,002. Woodline Partners already held ABCL in its Q4 2020 13F, the earliest on record, and held it in 7 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History